Purpose Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in stage 3 clinical advancement for glaucoma treatment. the trabecular outflow pathway had been looked into by confocal, light, and electron microscopy. Outcomes Perfusion with netarsudil-M1 considerably increased C in comparison with baseline (51%, 0.01) also to paired settings (102%, 0.01), aswell while significantly increased PEFL… Continue reading Purpose Netarsudil is a Rho kinase/norepinephrine transporter inhibitor currently in stage